Modafinil treatment of excessive sedation associated with divalproex sodium.
Berigan
Tim
T
D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects*; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000077408:Modafinil; D009771:Obsessive-Compulsive Disorder / Q000150:complications; D019966:Substance-Related Disorders / Q000150:complications; D014635:Valproic Acid / Q000009:adverse effects*
D018692:Antimanic Agents; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D014635:Valproic Acid; D000077408:Modafinil